SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.70-0.8%Jan 23 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (9118)3/11/1999 3:21:00 PM
From: aknahow  Read Replies (1) of 17367
 
Murphy said they have been accruing about 8 per week. He also says he thinks they need 4 weeks more to complete the trial. Would say perhaps this means 3 or 4 more deaths are required to reach the established level. We know it is not one more and probably not just two. When one assumes more than 3 or 4 then the time to conclusion of the trial moves beyond being close.

I hope XOMA never again agrees with any DSMB to keep vital information from shareholders. I think one can demonstrate that the decision to do so cost XOMA millions in capital by having to finance at prices that were lower than they should have been.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News